GLP-1 RAs were thus designed as synthetic GLP-1 mimetics resistant to DDP-4 degradation, allowing a prolonged insulinotropic response for people with T2DM and thus limiting postprandial glucose excursions. Here, GCG is linked to type 2 diabetes mellitus.